COVID-19 Research Paper Volume 13, Issue 6 pp 7733—7744

Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19

Serum cytokines on admission of cancer patients with COVID-19. Levels of TNF-α, IL-2R, IL-6, IL-8, and IL-10 were tested on admission of cancer patients with COVID-19 divided by the outcome (A). Levels of TNF-α, IL-2R, IL-6, IL-8, and IL-10 were increased in those patients who died from COVID-19 (B). Levels of TNF-α, IL-2R, IL-6, IL-8, and IL-10 were correlated with survival time of cancer patients with COVID-19 (C).

Figure 1. Serum cytokines on admission of cancer patients with COVID-19. Levels of TNF-α, IL-2R, IL-6, IL-8, and IL-10 were tested on admission of cancer patients with COVID-19 divided by the outcome (A). Levels of TNF-α, IL-2R, IL-6, IL-8, and IL-10 were increased in those patients who died from COVID-19 (B). Levels of TNF-α, IL-2R, IL-6, IL-8, and IL-10 were correlated with survival time of cancer patients with COVID-19 (C).